NovoCure Limited share price logo

NovoCure Limited Share Price

NASDAQ: NVCR

Small Cap

$12.07

+0.06

(+0.50%)

Live

as on

NovoCure Limited Stock Performance

as on March 14, 2026 at 1:47 am IST

  • Day's High

    $12.07
    $12.33

    2.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.82
    $20.87
    downward going graph

    18.64%

    Downside

    72.91%

    Upside

    downward going graph

NovoCure Limited share price movements today

Previous Close
$12.01
Open
$12.28
Volume
123.9K
Day's Low - High
$12.07 - $12.33
52 Week Low - High
$9.82 - $20.87

NovoCure Limited Historical Returns

1 Month Return
+ 9.28 %
3 Month Return
-9.83 %
1 Year Return
-40.13 %
3 Year Return
-82.34 %
5 Year Return
-91.32 %

NovoCure Limited Stock Fundamentals & Key Indicators

Check NovoCure Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-1.51

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.06%

PE Ratio (TTM)

-12.67

Industry PE ratio

7.871681415929204

PEG Ratio

-0.47

EBITDA

-135.2M

Revenue (TTM)

655.4M

Profit Margin

-20.79%

Return On Equity TTM

-38.89%

NovoCure Limited Stock Valuation

Track how NovoCure Limited P/E has moved over time to understand its valuation trends.

NovoCure Limited in the last 5 years

  • Overview

  • Trends

Lowest (-179.24x)

December 31, 2021

Today (-12.67x)

March 13, 2026

Industry (7.87x)

March 13, 2026

Highest (-6.86x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -12.67x

NovoCure Limited vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovoCure Limited with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.4B-91.32%-12.67-20.79%
BUY$103.3B76.45%35.8914.44%
BUY$132.3B40.06%41.1612.92%
BUY$114.2B-26.45%24.8513.00%
BUY$49.1B3.09%46.7517.69%

Stock Returns calculator for NovoCure Limited Stock including INR - Dollar returns

The NovoCure Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

NovoCure Limited investment value today

Current value as on today

₹66,479

Returns

₹33,521

(-33.52%)

Returns from NovoCure Limited Stock

₹39,831 (-39.83%)

Dollar Returns*

₹6,309 (+6.31%)

Analyst Recommendation on NovoCure Limited Stock

Based on 13 analysts

BUY

61.54%

Buy

38.46%

Hold

0.00%

Sell

Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for NovoCure Limited. Average target price of $25.93

NovoCure Limited Share Price Target

Get share price movements and forecasts by analysts on NovoCure Limited.

What analysts predicted

53.45%UPSIDE

Target Price

$25.93

Current Price

$12.07

Analyzed by

13 Analysts

Target

$25.93

NovoCure Limited target price $25.93, a slight upside of 53.45% compared to current price of $12.07. According to 13 analysts rating.

NovoCure Limited Stock’s Investor Sentiment and Interest

Investment in NovoCure Limited Shares on INDmoney has grown by 150.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:150.00% versus previous 30 day period

Search interest for NovoCure Limited Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:42% versus previous 30 day period

NovoCure Limited Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
127
133
138
150
155
161
154
158
167
174
Gross Profit
95
101
104
115
119
127
116
117
122
132
Operating Income
-58
-51
-41
-33
-32
-63
-37
-39
-36
-40
EBITDA
-55
-35
-38
-30
-29
-10
-34
-36
-26
-34
Interest Expense
-
9
-
-
-
-
-
-
-
-
Depreciation
2
2
2
2
2
3
3
3
3
4
Income Before Tax
-48
-38
-31
-22
-21
-55
-30
-34
-30
-40
Income Tax Expense
1
8
7
10
8
10
4
5
7
-16
Net Income
-49
-47
-38
-33
-30
-65
-34
-40
-37
-24
Net Profit Margin
-38.87%
-35.19%
-27.98%
-22.20%
-19.71%
-40.88%
-22.14%
-25.28%
-22.29%
-14.05%

NovoCure Limited Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
82
177
248
351
494
535
537
509
605
655
Gross Profit
36
121
168
262
387
420
422
381
468
488
Operating Income
-115
-39
-33
0
30
-44
-89
-232
-170
-153
EBITDA
-109
-31
-24
7
44
-34
-78
-177
-109
-119
Interest Expense
5
10
13
13
18
3
3
4
11
17
Depreciation
-
7
9
8
9
10
10
10
11
14
Income Before Tax
-121
-48
-45
-8
18
-52
-81
-191
-131
-136
Income Tax Expense
10
13
17
-1
-1
6
10
15
37
0
Net Income
-131
-61
-63
-7
19
-58
-92
-207
-168
-136
Net Profit Margin
-159.06%
-34.83%
-25.62%
-2.06%
4.01%
-10.91%
-17.20%
-40.65%
-27.86%
-20.79%

NovoCure Limited Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-47
-38
-33
-30
-65
-34
-40
-37
-24
Operating Cash Flow
-14
-31
-1
10
-3
-35
-15
20
-18
Investing Cash Flow
98
246
-374
10
-22
-6
35
71
336
Financing Cash Flow
1
0
87
0
2
5
2
100
-559
Change in Cash
86
214
-288
20
-23
-36
22
192
-241

NovoCure Limited Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-61
-63
-7
19
-58
-92
-207
-168
-136
Operating Cash Flow
-33
-1
26
99
82
30
-73
-26
-49
Investing Cash Flow
6
-5
-51
-472
-144
-139
184
-140
437
Financing Cash Flow
5
69
61
440
25
15
15
90
-451
Change in Cash
-21
62
36
66
-36
-93
126
-76
-62

Global Institutional Holdings in NovoCure Limited

Funds
Holdings
Quantinno Capital Management LP
1.34%
Palo Alto Investors, LLC
1.1%
American Century Companies Inc
0.92%
CAM Group Holding A/S
0.85%
Northern Trust Corp
1.02%

Insights on NovoCure Limited

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -40.13M → -24.49M (in $), with an average increase of 29.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 154.99M → 174.35M (in $), with an average increase of 3.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 10.4% return, outperforming this stock by 92.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 24.5% return, outperforming this stock by 64.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NVCR stock has moved down by -7.9%

About NovoCure Limited

we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.
OrganisationNovoCure Limited
HeadquartersNeuhofstrasse 21, Baar, Switzerland, 6340
IndustryHealth Technology
CEOMr. Frank Leonard
E-voting on sharesClick here to vote

Key Management of NovoCure Limited

Name

Title

Mr. William F. Doyle

Executive Chairman

Mr. Frank Leonard

Chief Executive Officer

Mr. Barak Ben-Arye

General Counsel

Dr. Uri Weinberg M.D., Ph.D.

Chief Innovation Officer & Chief Medical Officer

Mr. Christoph Brackmann

Chief Financial Officer

Mr. Mukund Paravasthu

Chief Operating Officer

Mr. Michael Puri

Chief Human Resources Officer

FAQs

What is NovoCure Limited share price today?

NovoCure Limited share price today is $12.07 as on . NovoCure Limited share today touched a day high of $12.33 and a low of $12.07.

What is the 52 week high and 52 week low for NovoCure Limited share?

NovoCure Limited share touched a 52 week high of $20.87 on and a 52 week low of $9.82 on . NovoCure Limited stock price today i.e. is trending at $12.07,which is 42.17% down from its 52 week high and 22.91% up from its 52 week low.

What is NovoCure Limited's market capitalisation today?

NovoCure Limited market capitalisation is $0.00T as on .

How to invest in NovoCure Limited Stock (NVCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NovoCure Limited on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovoCure Limited Shares that will get you 0.1243 shares as per NovoCure Limited share price of $12.07 per share as on March 13, 2026 at 8:17 pm IST.

What is the minimum amount required to buy NovoCure Limited Stock (NVCR) from India?

Indian investors can start investing in NovoCure Limited (NVCR) shares with as little as ₹92.409 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.09 in NovoCure Limited stock (as per the Rupee-Dollar exchange rate as on ). Based on NovoCure Limited share’s latest price of $12.07 as on March 13, 2026 at 8:17 pm IST, you will get 0.8285 shares of NovoCure Limited. Learn more about fractional shares .

What are the returns that NovoCure Limited has given to Indian investors in the last 5 years?

NovoCure Limited stock has given -91.32% share price returns and 26.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?